Go Pro
→ Why major institutions are piling into this digital asset now (From Awesomely) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fremont Gold Ltd. stock logo
FRE
Fremont Gold
C$0.15
C$0.15
C$0.05
▼
C$0.17
C$8.71M0.4340,741 shs28,000 shs
Medifast Inc stock logo
MED
Medifast
$11.57
+2.5%		$10.92
$9.22
▼
$14.67
$126.23M0.65201,376 shs129,375 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fremont Gold Ltd. stock logo
FRE
Fremont Gold
0.00%0.00%0.00%0.00%0.00%
Medifast Inc stock logo
MED
Medifast
+2.40%-0.08%+11.05%-8.17%-18.33%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fremont Gold Ltd. stock logo
FRE
Fremont Gold
C$0.15
C$0.15
C$0.05
▼
C$0.17
C$8.71M0.4340,741 shs28,000 shs
Medifast Inc stock logo
MED
Medifast
$11.57
+2.5%		$10.92
$9.22
▼
$14.67
$126.23M0.65201,376 shs129,375 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fremont Gold Ltd. stock logo
FRE
Fremont Gold
0.00%0.00%0.00%0.00%0.00%
Medifast Inc stock logo
MED
Medifast
+2.40%-0.08%+11.05%-8.17%-18.33%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fremont Gold Ltd. stock logo
FRE
Fremont Gold
0.00
N/AN/AN/A
Medifast Inc stock logo
MED
Medifast
1.67
Reduce$12.003.71% Upside

Current Analyst Ratings Breakdown

Latest MED and FRE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/17/2026
Medifast Inc stock logo
MED
Medifast
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D)
8/11/2026
Medifast Inc stock logo
MED
Medifast
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/3/2026
Medifast Inc stock logo
MED
Medifast
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/13/2026
Medifast Inc stock logo
MED
Medifast
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
(Data available from 8/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fremont Gold Ltd. stock logo
FRE
Fremont Gold
N/AN/AC$0.08 per share1.84C$0.01 per shareN/A
Medifast Inc stock logo
MED
Medifast
$385.79M0.34$0.43 per share27.20$17.56 per share0.66
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fremont Gold Ltd. stock logo
FRE
Fremont Gold
-C$6.24M-C$0.11N/AN/AN/AN/A-257.67%-104.83%N/A
Medifast Inc stock logo
MED
Medifast
-$18.67M-$2.33N/AN/AN/A-8.08%-6.69%-5.25%11/2/2026 (Estimated)

Latest MED and FRE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/3/2026Q2 2026
Medifast Inc stock logo
MED
Medifast
-$0.65-$0.28+$0.37-$0.28$72.70 million$76.38 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Fremont Gold Ltd. stock logo
FRE
Fremont Gold
N/A12.12%N/AN/AN/A
Medifast Inc stock logo
MED
Medifast
N/AN/A-100.00%N/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fremont Gold Ltd. stock logo
FRE
Fremont Gold
N/A
0.89
1.79
Medifast Inc stock logo
MED
Medifast
N/A
4.86
4.35

Institutional Ownership

CompanyInstitutional Ownership
Fremont Gold Ltd. stock logo
FRE
Fremont Gold
0.69%
Medifast Inc stock logo
MED
Medifast
95.51%

Insider Ownership

CompanyInsider Ownership
Fremont Gold Ltd. stock logo
FRE
Fremont Gold
22.50%
Medifast Inc stock logo
MED
Medifast
3.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Fremont Gold Ltd. stock logo
FRE
Fremont Gold
N/A58.07 millionN/ANot Optionable
Medifast Inc stock logo
MED
Medifast
87011.18 million10.77 millionOptionable

Recent News About These Companies

Medifast (NYSE:MED) Cut to Hold at Zacks Research
August 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/medifast-nysemed-cut-to-hold-at-zacks-research-2026-08-13/
Can Medifast's Coach Productivity Gains Help Revive Revenue Growth?
August 12, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2973756/can-medifast-s-coach-productivity-gains-help-revive-revenue-growth?cid=cs-stocknewsapi-ft-analyst_blog|rank_focused-2973756
Medifast’s Q2 earnings call: Our top 5 analyst questions
August 10, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/medifast-s-q2-earnings-call-our-top-5-analyst-questions/ar-AA29KJP7
Is MED Worth Buying as Low Valuation Meets a High-Risk Turnaround?
August 7, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2971410/is-med-worth-buying-as-low-valuation-meets-a-high-risk-turnaround?cid=cs-stocknewsapi-ft-analyst_blog_plus|zer_report_insights-2971410
MED Rallies 13.6% in the Past Month: Can the Momentum Keep Building?
August 7, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2971412/med-rallies-13-6-in-the-past-month-can-the-momentum-keep-building?cid=cs-stocknewsapi-ft-analyst_blog_plus|zer_report_insights-2971412
Can MED's Trilivy Launch and Cost Cuts Drive a Q4 Profit Turnaround?
August 7, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2971415/can-med-s-trilivy-launch-and-cost-cuts-drive-a-q4-profit-turnaround?cid=cs-stocknewsapi-ft-analyst_blog_plus|zer_report_insights-2971415
Medifast: Worth A Speculative Entry As Sales Stabilize (Rating Upgrade)
August 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4931381-medifast-stock-worth-speculative-entry-sales-stabilize-rating-upgrade?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=article?source=MarketBeat
Medifast Earnings Call: Transformation Amid Revenue Strain
August 4, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/medifast-earnings-call-transformation-amid-revenue-strain?utm_source=marketbeat.com&utm_medium=referral
Medifast: Q2 Earnings Snapshot
August 4, 2026  |  aol.comA
Medifast rebrands flagship diet product amid pressure from GLP-1s
August 4, 2026  |  bizjournals.comhttps://www.bizjournals.com/baltimore/news/2026/08/04/medifast-rebrand-optavia-diet-obesity.html
Medifast surges on Q2 earnings beat as turnaround gains traction
August 4, 2026  |  msn.comhttps://www.msn.com/en-us/money/other/medifast-surges-on-q2-earnings-beat-as-turnaround-gains-traction/ar-AA29o8nk
Medifast Q2 Loss Narrower Than Expected, Coach Productivity Improves
August 4, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2967817/medifast-q2-loss-narrower-than-expected-coach-productivity-improves?cid=cs-stocknewsapi-ft-analyst_blog|earnings_article-2967817
Medifast targets return to profitability in Q4 2026 as Trilivy rollout continues
August 4, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4624275-medifast-targets-return-to-profitability-in-q4-2026-as-trilivy-rollout-continues
Medifast, Inc. (MED) Q2 2026 Earnings Call Transcript
August 4, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4929692-medifast-inc-med-q2-2026-earnings-call-transcript
Medifast Q2 Earnings Call Highlights
August 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/medifast-q2-earnings-call-highlights-2026-08-03/
Medifast (NYSE:MED) beats expectations in strong Q2 CY2026, stock jumps 12.8%
August 3, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/medifast-nyse-med-beats-expectations-in-strong-q2-cy2026-stock-jumps-12-8/ar-AA29kmUo
Medifast Revolutionizes Metabolic Health with 3.0 Strategy, Stabilized Revenue and Growing Coach Productivity
August 3, 2026  |  news.themarketisopen.comN
Medifast (MED) Reports Q2 Loss, Beats Revenue Estimates
August 3, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2967027/medifast-med-reports-q2-loss-beats-revenue-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_4-2967027
Medifast (NYSE:MED) Updates Q3 2026 Earnings Guidance
August 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/medifast-nysemed-updates-q3-2026-earnings-guidance-2026-08-03/
Medifast (NYSE:MED) Updates FY 2026 Earnings Guidance
August 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/medifast-nysemed-updates-fy-2026-earnings-guidance-2026-08-03/
Medifast Q2 revenue falls 28 percent to $76.4 million
August 3, 2026  |  quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

Fremont Gold stock logo

Fremont Gold CVE:FRE

C$0.15 0.00 (0.00%)
As of 11/5/2024

Fremont Gold Ltd., an exploration stage company, engages in the acquisition, exploration, and evaluation of mineral properties in the United States and Canada. The company explores for gold and copper deposit. The company was formerly known as Palisades Ventures Inc. and changed its name to Fremont Gold Ltd. in June 2017. Fremont Gold Ltd. was incorporated in 2007 and is headquartered in Vancouver, Canada.

Medifast stock logo

Medifast NYSE:MED

$11.57 +0.28 (+2.49%)
Closing price 08/19/2026 03:59 PM Eastern
Extended Trading
$11.48 -0.10 (-0.83%)
As of 08/19/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas